Non-alcoholic steatohepatitis-related liver cirrhosis is increasing in China: A ten-year retrospective study

被引:22
|
作者
Xiong, Ji [1 ]
Wang, Jun [1 ,2 ]
Huang, Juan [1 ]
Sun, Wenjing [1 ]
Wang, Jun [1 ,2 ]
Chen, Dongfeng [1 ]
机构
[1] Third Mil Med Univ, Inst Surg Res, Daping Hosp, Dept Gastroenterol, Chongqing, Peoples R China
[2] Chinese Peoples Armed Police Force, Med Team, Xinjiang, Peoples R China
基金
中国国家自然科学基金;
关键词
Non-Alcoholic Steatohepatitis; Non-Alcoholic Fatty Liver Disease; Liver Cirrhosis; Obesity; Metabolism; HEPATITIS-B-VIRUS; HEPATOCELLULAR-CARCINOMA; METABOLIC SYNDROME; NATURAL-HISTORY; RISK-FACTORS; DISEASE; EPIDEMIOLOGY; OBESITY; PROGRESSION; INFECTION;
D O I
10.6061/clinics/2015(08)06
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
OBJECTIVE: Little is known about metabolic factors in cirrhotic patients in China. Therefore, we aimed to quantify the prevalence of both metabolic factors and non-alcoholic steatohepatitis-related liver cirrhosis in China. METHODS: The medical records of 1,582 patients diagnosed with liver cirrhosis from June 2003 to July 2013 at Daping Hospital (Chongqing, China) were retrospectively reviewed through a computer-generated search. RESULTS: Serum hepatitis B virus surface antigen was present in 1,083 (68.5%) patients, and hepatitis B was found to be the only etiological factor in 938 (59.3%) of all patients. Obesity, diabetes mellitus, and arterial hypertension were observed in 229 (14.5%), 159 (10.1%), and 129 (8.2%) patients, respectively. From 2012-2013, the proportion of non-alcoholic steatohepatitis-related liver cirrhosis increased to 3.2%, whereas the average proportion of nonalcoholic steatohepatitis-related liver cirrhosis in the previous ten years was 1.9%. The incidence of hepatocellular carcinoma was much higher in males than in females (6.3% vs. 3.7%, respectively, p=0.036). Obesity and diabetes mellitus did not significantly increase the incidence of hepatocellular carcinoma in the whole cirrhotic group. The presence of hepatitis B virus was the only risk factor for hepatocellular carcinoma in cirrhotic patients (p<0.001). CONCLUSIONS: Although hepatitis B virus remains the main etiology of liver cirrhosis in China, steatohepatitis-related liver cirrhosis is increasing in frequency. Hepatitis B virus was the sole significant risk factor for hepatocellular carcinoma in the whole cirrhotic group in the present study, in contrast to obesity and diabetes mellitus, for which only a trend of increased hepatocellular carcinoma was found.
引用
收藏
页码:563 / 568
页数:6
相关论文
共 50 条
  • [1] The evaluation of complications and mortality in non-alcoholic steatohepatitis-related cirrhosis
    Vatansever, Sezgin
    Pakoz, Zehra Betul
    MARMARA MEDICAL JOURNAL, 2019, 32 (01): : 44 - 49
  • [2] A Clinical Score Predicts Non-Alcoholic Steatohepatitis-Related Liver Disease from Alcoholic Liver Disease
    Kakati, Donny
    Raff, Evan
    Bloomer, Joseph
    Shoreibah, Mohamed
    Rasheed, Khalid
    Singal, Ashwani
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2013, 108 : S130 - S130
  • [3] Non-Alcoholic Steatohepatitis-Related Hepatocellular Carcinoma: A Growing Epidemic?
    Yopp, Adam C.
    Choti, Michael A.
    DIGESTIVE DISEASES, 2015, 33 (05) : 642 - 647
  • [4] Low liver fat in non-alcoholic steatohepatitis-related significant fibrosis and cirrhosis is associated with hepatocellular carcinoma, decompensation and mortality
    Lee, Sung Won
    Huang, Daniel Q.
    Bettencourt, Ricki
    Ajmera, Veeral
    Tincopa, Monica
    Noureddin, Nabil
    Amangurbanova, Maral
    Siddiqi, Harris
    Madamba, Egbert
    Majzoub, Abdul M.
    Nayfeh, Tarek
    Tamaki, Nobuharu
    Izumi, Namiki
    Nakajima, Atsushi
    Yoneda, Masato
    Idilman, Ramzan
    Gumussoy, Mesut
    Oz, Digdem Kuru
    Erden, Ayse
    Loomba, Rohit
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2024, 59 (01) : 80 - 88
  • [5] Non-alcoholic steatohepatitis-related cirrhosis in a patient with APOB L343V familial hypobetalipoproteinaemia
    Heeks, Lies V.
    Hooper, Amanda J.
    Adams, Leon A.
    Robbins, Peter
    Barrett, P. Hugh R.
    van Bockxmeer, Frank M.
    Burnett, John R.
    CLINICA CHIMICA ACTA, 2013, 421 : 121 - 125
  • [6] A ROLE OF MTOR PATHWAY IN THE DIAGNOSIS OF NON ALCOHOLIC STEATOHEPATITIS-RELATED CIRRHOSIS
    Kubrusly, Marcia S.
    Correa-Giannella, Maria Lucia
    Sa, Sandra V.
    Bellodi-Privato, Marta
    Soares, Ibere C.
    Alves, Venancio A.
    Bacchella, Telesforo
    Machado, Marcel C.
    Oliveira, Claudia P.
    HEPATOLOGY, 2008, 48 (04) : 523A - 524A
  • [7] Effectiveness of farnesyltransferase inhibitor on non-alcoholic steatohepatitis-related hepatocellular carcinoma
    Yamada, Kohei
    Tanaka, Tomokazu
    Matsufuji, Shohei
    Ito, Kotaro
    Egawa, Noriyuki
    Noshiro, Hirokazu
    CANCER SCIENCE, 2021, 112 : 801 - 801
  • [8] Impaired Response to Immunotherapy in Non-Alcoholic Steatohepatitis-Related Hepatocellular Carcinoma?
    Kudo, Masatoshi
    LIVER CANCER, 2021, 10 (04) : 289 - 295
  • [9] Agreement between wedged hepatic venous pressure and portal pressure in non-alcoholic steatohepatitis-related cirrhosis
    Ferrusquia-Acosta, Jose
    Bassegoda, Octavi
    Turco, Laura
    Reverter, Enric
    Pellone, Monica
    Bianchini, Marcello
    Perez-Campuzano, Valeria
    Ripoll, Enric
    Garcia-Criado, Angeles
    Graupera, Isabel
    Garcia-Pagan, Juan Carlos
    Schepis, Filippo
    Senzolo, Marco
    Hernandez-Gea, Virginia
    JOURNAL OF HEPATOLOGY, 2021, 74 (04) : 811 - 818
  • [10] Non-alcoholic steatohepatitis-related liver tumorigenesis is suppressed in mice lacking hepatic retinoid storage
    Ideta, Takayasu
    Shirakami, Yohei
    Ohnishi, Masaya
    Maruta, Akinori
    Obara, Koki
    Miyazaki, Tsuneyuki
    Kochi, Takahiro
    Sakai, Hiroyasu
    Tomita, Hiroyuki
    Tanaka, Takuji
    Blaner, William S.
    Shimizu, Masahito
    ONCOTARGET, 2017, 8 (41) : 70695 - 70706